financetom
Business
financetom
/
Business
/
ZoomInfo Q2 Adjusted Earnings, Revenue Rise, Ups Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ZoomInfo Q2 Adjusted Earnings, Revenue Rise, Ups Guidance
Aug 4, 2025 2:51 PM

05:34 PM EDT, 08/04/2025 (MT Newswires) -- ZoomInfo Technologies ( GTM ) reported Q2 adjusted earnings late Monday of $0.25 per diluted share, up from $0.17 per share a year earlier.

Analysts polled by FactSet expected $0.23 per share.

Revenue for the quarter ended June 30 was $306.7 million, up from $291.5 million a year earlier.

Analysts surveyed by FactSet expected $296.3 million.

For Q3, it projects adjusted EPS of $0.24 to $0.26 on revenue of

$302 million to $305 million. Analysts expected $0.25 and $298 million, respectively.

For 2025, the company now expects EPS of $0.99 to $1.01 on revenue of $1.215 billion to $1.225 billion, up from prior range of $0.96 to $0.98 on $1.195 billion to $1.205 billion revenue.

Analysts expected $0.97 and $1.2 billion, respectively.

The shares were up over 3% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US airlines say it is 'imperative' FAA get quick wins in air traffic overhaul
US airlines say it is 'imperative' FAA get quick wins in air traffic overhaul
Oct 8, 2025
WASHINGTON (Reuters) -A group representing major U.S. airlines said it is imperative the Federal Aviation Administration accomplish some quick wins in the $12.5 billion overhaul of the aging air traffic control system, according to a letter seen by Reuters on Wednesday. Airlines for America CEO Chris Sununu in a previously unreported letter to Transportation Secretary Sean Duffy said the FAA...
Zenas Biopharma Raises $120 Million To Secure Global Rights To Multiple Sclerosis Drug
Zenas Biopharma Raises $120 Million To Secure Global Rights To Multiple Sclerosis Drug
Oct 8, 2025
Zenas BioPharma Inc. ( ZBIO ) and InnoCare Pharma Ltd. on Wednesday announced a license agreement granting Zenas global development and commercialization rights to orelabrutinib for multiple sclerosis and across all therapeutic areas other than oncology. ZBIO is delivering impressive returns. Review the technical setup here. Zenas also secured rights to a novel, oral, IL-17AA/AF inhibitor and an oral, brain-penetrant,...
Google to invest 5 billion euros in Belgium, creating 300 jobs
Google to invest 5 billion euros in Belgium, creating 300 jobs
Oct 8, 2025
BRUSSELS, Oct 8 (Reuters) - U.S. tech giant Google announced on Wednesday plans to invest 5 billion euros ($5.80 billion) in Belgium, which the compay said would create a further 300 jobs in the country. Google added the investment would focus on the AI sector and on expanding its data centre campuses in Belgium. Google also announced deals to support...
--Corning Keeps Quarterly Dividend at $0.28 a Share, Payable Dec. 12 to Shareholders of Record as of Nov. 14
--Corning Keeps Quarterly Dividend at $0.28 a Share, Payable Dec. 12 to Shareholders of Record as of Nov. 14
Oct 8, 2025
01:55 PM EDT, 10/08/2025 (MT Newswires) -- Price: 86.29, Change: +1.23, Percent Change: +1.45 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved